IRON AMINOS 5-AMINO-1MQ 50MG
Research-grade NNMT-pathway compound prepared for consistency and clean documentation in professional lab workflows.
Key Features
-
50mg 5-Amino-1MQ per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot/batch labeling for traceability
-
Signature Iron Aminos red-honeycomb label for quick identification
-
Diluent/solvent not included
Specifications
-
Compound: 5-Amino-1-methylquinolinium (1-MQ)
-
Category/Target: Nicotinamide N-methyltransferase (NNMT) inhibitor research compound
-
Form / appearance: Lyophilized powder, white to off-white
-
Amount: 50mg per vial
-
Purity: ≥99%
-
Storage (lyophilized): Cool, dry place away from light
-
Storage (after reconstitution): Refrigerate; use promptly per internal SOP
What’s Included
-
1 × 5-Amino-1MQ 50mg vial (no diluent/solvent)
Handling
Use an appropriate, compatible solvent per your protocol and laboratory SOPs. Confirm solubility in the intended vehicle and, if required, pass through a sterile filter (0.22 µm) under aseptic technique.
Research Snapshot
-
5-Amino-1MQ is studied as a selective inhibitor of NNMT, an enzyme that methylates nicotinamide using SAM as a methyl donor.
-
In preclinical metabolic models, NNMT inhibition has been associated with reduced adiposity, improved insulin sensitivity, and shifts in cellular methylation/energy metabolism pathways.
-
Additional exploratory work evaluates effects on NAD⁺/nicotinamide handling, lipid/glucose metabolism, and tumor-cell bioenergetics.
-
The compound remains investigational; dose, route, and off-target profiles are protocol-dependent, and human efficacy/safety data are limited.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
